SCHEMBL3759783

SCHEMBL3759783

CC(C)COc1cccc(-c2c(N3CCOCC3)sc3c2CC(C)(C)CC3=O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
MAPK1 P28482 2/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PIK3CD O00329 1/20 0.37
PIK3CA P42336 1/20 0.37
PIK3CB P42338 1/20 0.37
PIK3CG P48736 1/20 0.37
WRN Q14191 2/20 0.37
ATM Q13315 5/20 0.35
PRKDC P78527 3/20 0.35
BRD4 O60885 1/20 0.35
CARM1 Q86X55 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3761691 0.90 WRN (0.44) MEN1KMT2AMAPK1USP2ALDH1A1
SCHEMBL3754814 0.87 PRKDC (0.46) MEN1KMT2AMAPK1USP2ALDH1A1
SCHEMBL3760440 0.87 PRKDC (0.51) ALDH1A1PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL3759252 0.85 PRKDC (0.47) MEN1KMT2AMAPK1USP2ALDH1A1
SCHEMBL3766054 0.85 PRKDC (0.43) PIK3CDPIK3CAPIK3CBPIK3CGATM
SCHEMBL3754793 0.84 CARM1 (0.38) KMT2AMAPK1USP2TSHRPIK3CD
SCHEMBL3757704 0.82 PIK3CD (0.42) HSD17B10PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL3758948 0.82 PIK3CD (0.42) MEN1KMT2AMAPK1USP2ALDH1A1
SCHEMBL3764864 0.81 PIK3CA (0.42) ALDH1A1HSD17B10PIK3CDPIK3CAPIK3CB
SCHEMBL3760569 0.81 PRKDC (0.46) MAPK1ALDH1A1PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA MEN1 2762/4885KMT2A 2175/4885MAPK1 178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.